Form 4: Omega Healthcare Investors Director Callen Receives and Converts Profits Interest Units

Sentiment:

SEC Form 4


Director Craig R. Callen of Omega Healthcare Investors Inc. reports the acquisition and conversion of Profits Interest Units (PIUs) into OP Units and common stock.

Summary

  • Craig R. Callen, a director of Omega Healthcare Investors Inc., reported transactions involving Profits Interest Units (PIUs) and OP Units on June 7, 2024.
  • Callen acquired 12,144 PIUs, which he elected to receive as an annual grant of stock, at a price of $0.
  • He also converted 13,144 vested PIUs into OP Units.
  • Additionally, Callen converted 13,144 OP Units into common stock.
  • Following these transactions, Callen beneficially owns 35,689 OP Units and 40,502 shares of common stock.
  • The PIUs granted on June 7, 2024, will vest on the date of the Company's 2025 Annual Meeting of Shareholders, subject to continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine insider transactions. There are no explicit positive or negative implications for the company's performance.

Positives

  • The director's acquisition of PIUs and conversion to common stock demonstrates continued alignment with the company's performance.

Future Outlook

The PIUs granted on June 7, 2024, will vest on the date of the Company's 2025 Annual Meeting of Shareholders, subject to continued service.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company directors.

Comparison to Industry Standards

  • Insider transactions are a normal part of corporate governance and are regularly disclosed by directors and officers of publicly traded companies.
  • Companies like Ventas (VTR), Welltower (WELL), and Healthpeak Properties (PEAK) also have similar insider transaction filings.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding the director's holdings and alignment with company interests.

Key Dates

DateDescription
February 9, 2022Date of Power of Attorney execution.
June 5, 2023Date of previous PIU grant that vested on June 7, 2024.
June 7, 2024Date of transactions involving PIUs, OP Units, and common stock.
June 11, 2024Date of signature on the Form 4 filing.
2025 Annual Meeting of ShareholdersVesting date for PIUs granted on June 7, 2024.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.